Success Metrics

Clinical Success Rate
91.2%

Based on 31 completed trials

Completion Rate
91%(31/34)
Active Trials
122(62%)
Results Posted
6%(2 trials)
Terminated
3(2%)

Phase Distribution

Ph not_applicable
88
45%
Ph phase_1
8
4%
Ph phase_4
4
2%
Ph phase_2
26
13%
Ph phase_3
4
2%
Ph early_phase_1
5
3%

Phase Distribution

13

Early Stage

26

Mid Stage

8

Late Stage

Phase Distribution135 total trials
Early Phase 1First-in-human
5(3.7%)
Phase 1Safety & dosage
8(5.9%)
Phase 2Efficacy & side effects
26(19.3%)
Phase 3Large-scale testing
4(3.0%)
Phase 4Post-market surveillance
4(3.0%)
N/ANon-phased studies
88(65.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.8%

31 of 37 finished

Non-Completion Rate

16.2%

6 ended early

Currently Active

122

trials recruiting

Total Trials

197

all time

Status Distribution
Active(151)
Completed(31)
Terminated(6)
Other(9)

Detailed Status

Recruiting101
Completed31
Not yet recruiting23
Active, not recruiting21
Enrolling by invitation6
Suspended5

Development Timeline

Analytics

Development Status

Total Trials
197
Active
122
Success Rate
91.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 15 (3.7%)
Phase 18 (5.9%)
Phase 226 (19.3%)
Phase 34 (3.0%)
Phase 44 (3.0%)
N/A88 (65.2%)

Trials by Status

unknown42%
withdrawn32%
recruiting10151%
terminated32%
enrolling_by_invitation63%
suspended53%
active_not_recruiting2111%
completed3116%
not_yet_recruiting2312%

Recent Activity

Clinical Trials (197)

Showing 20 of 197 trialsScroll for more
NCT06112613Not Applicable

Mobile Health for Adherence in Breast Cancer Patients

Recruiting
NCT05679349Not Applicable

Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

Recruiting
NCT04829136Not Applicable

Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies

Recruiting
NCT05705531

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Recruiting
NCT06112847Phase 2

Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma

Active Not Recruiting
NCT06513962Phase 3

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Recruiting
NCT04929015Not Applicable

Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)

Suspended
NCT05055011

Parental Attitudes and Beliefs Regarding Risks Associated With Opioid Use in Children With Cancer

Active Not Recruiting
NCT06995898Not Applicable

The Vanguard Study: Testing a New Way to Screen for Cancer

Recruiting
NCT05410977

Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients

Recruiting
NCT05056857

Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen

Recruiting
NCT07529483Phase 2

Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cystic Neoplasms

Not Yet Recruiting
NCT05612100

Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients

Recruiting
NCT06064097Phase 2

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

Recruiting
NCT06611540Not Applicable

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)

Active Not Recruiting
NCT06611553Not Applicable

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)

Active Not Recruiting
NCT07553819Not Applicable

Home-Based Respiratory Muscle Training and Aerobic Exercise Programs to Improve Lung Health in Current and Former Cigarette Smokers

Not Yet Recruiting
NCT04856046

Detection of Plasma DNA Methylation in Peripheral Blood From Patients With Resectable Liver Cancer

Active Not Recruiting
NCT04829539Phase 3

Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment

Active Not Recruiting
NCT07548983Phase 1

Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation

Not Yet Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
197